RTP801 Is Induced in Parkinson's Disease and Mediates Neuron Death by Inhibiting Akt Phosphorylation/Activation

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

Sarbassov, D. D., Guertin, D. A., Ali, S. M., & Sabatini, D. M. (2005) · Science · doi:10.1126/science.1106148 · Cited by 6,216 · see citing works

Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery

Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689 · see citing works

Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.

Greene, L., & Tischler, A. S. (1976) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.73.7.2424 · Cited by 5,594 · see citing works

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

Cross, D. A. E., Alessi, D. R., Cohen, P., Andjelkovich, M., & Hemmings, B. A. (1995) · Nature · doi:10.1038/378785a0 · Cited by 5,244 · see citing works

Mechanism of activation of protein kinase B by insulin and IGF‐1.

Alessi, D. R., Andjelković, M., Caudwell, B., Cron, P. D., MORRICE, N. A., Cohen, P., & Hemmings, B. A. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01045.x · Cited by 2,985 · see citing works

mTOR Interacts with Raptor to Form a Nutrient-Sensitive Complex that Signals to the Cell Growth Machinery

Kim, D., Sarbassov, D. D., Ali, S. M., King, J. E., Latek, R. R., Erdjument‐Bromage, H., Tempst, P., & Sabatini, D. M. (2002) · Cell · doi:10.1016/s0092-8674(02)00808-5 · Cited by 2,974 · see citing works

Rictor, a Novel Binding Partner of mTOR, Defines a Rapamycin-Insensitive and Raptor-Independent Pathway that Regulates the Cytoskeleton

Sarbassov, D. D., Ali, S. M., Kim, D.-H., Guertin, D. A., Latek, R. R., Erdjument-Bromage, H., Tempst, P., & Sabatini, D. M. (2004) · Current Biology · doi:10.1016/j.cub.2004.06.054 · Cited by 2,665 · see citing works

Regulation of neuronal survival by the serine-threonine protein kinase Akt

Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436 · see citing works

Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease

Ravikumar, B., Vacher, C., Berger, Z., Davies, J. E., Luo, S., Oroz, L. G., Scaravilli, F., Easton, D. F., Duden, R., O'Kane, C. J., et al. (2004) · Nature Genetics · doi:10.1038/ng1362 · Cited by 2,347 · see citing works

Interleukin-3-Induced Phosphorylation of BAD Through the Protein Kinase Akt

del Peso, L., González‐García, M., Page, C., Herrera, R., & Núñez, G. (1997) · Science · doi:10.1126/science.278.5338.687 · Cited by 2,213 · see citing works

Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive

Jacinto, E., Loewith, R., Schmidt, A., Lin, S., Rüegg, M. A., Hall, A., & Hall, M. N. (2004) · Nature Cell Biology · doi:10.1038/ncb1183 · Cited by 2,097 · see citing works

Raptor, a Binding Partner of Target of Rapamycin (TOR), Mediates TOR Action

Hara, K., Maruki, Y., Long, X., Yoshino, K.-I., Oshiro, N., Sujuti, H., Tokunaga, C., Avruch, J., & Yonezawa, K. (2002) · Cell · doi:10.1016/s0092-8674(02)00833-4 · Cited by 1,810 · see citing works

PI3K: Downstream AKTion Blocks Apoptosis

Franke, T. F., Kaplan, D. R., & Cantley, L. C. (1997) · Cell · doi:10.1016/s0092-8674(00)81883-8 · Cited by 1,692 · see citing works

Direct Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate

Franke, T. F., Kaplan, D., Cantley, L., & Toker, A. (1997) · Science · doi:10.1126/science.275.5300.665 · Cited by 1,609 · see citing works

SIN1/MIP1 Maintains rictor-mTOR Complex Integrity and Regulates Akt Phosphorylation and Substrate Specificity

Jacinto, E., Facchinetti, V., Liu, D., Soto, N., Wei, S., Jung, S. Y., Huang, Q., Qin, J., & Su, B. (2006) · Cell · doi:10.1016/j.cell.2006.08.033 · Cited by 1,407 · see citing works

Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex

Brugarolas, J., Lei, K., Hurley, R. L., Manning, B. D., Reiling, J. H., Hafen, E., Witters, L. A., Ellisen, L. W., & Kaelin, W. G. (2004) · Genes & Development · doi:10.1101/gad.1256804 · Cited by 1,384 · see citing works

A transforming mutation in the pleckstrin homology domain of AKT1 in cancer

Carpten, J. D., Faber, A. L., Horn, C. L., Donoho, G. P., Briggs, S., Robbins, C. M., Hostetter, G. H., Boguslawski, S. J., Moses, T. Y., Savage, S., et al. (2007) · Nature · doi:10.1038/nature05933 · Cited by 1,291 · see citing works

Transcription-dependent and -independent control of neuronal survival by the PI3K–Akt signaling pathway

Brunet, A., Datta, S. R., & Greenberg, M. E. (2001) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00211-7 · Cited by 1,193 · see citing works

Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.

Anglade, P., Vyas, S., Javoy-Agid, F., Herrero, M. T., Michel, P. P., Marquez, J., Prigent, A., Ruberg, M., Hirsch, É. C., & Agid, Y. (1997) · PubMed · Cited by 1,045 · see citing works

Antiapoptotic Signalling by the Insulin-Like Growth Factor I Receptor, Phosphatidylinositol 3-Kinase, and Akt

Kulik, G., Klippel, A., & Weber, M. J. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.3.1595 · Cited by 1,033 · see citing works

Hypoxia regulates TSC1/2–mTOR signaling and tumor suppression through REDD1-mediated 14–3–3 shuttling

DeYoung, M. P., Horak, P., Sofer, A., Sgroi, D., & Ellisen, L. W. (2008) · Genes & Development · doi:10.1101/gad.1617608 · Cited by 710 · see citing works

Regulation of Dendritic Morphogenesis by Ras–PI3K–Akt–mTOR and Ras–MAPK Signaling Pathways

Kumar, V., Zhang, M.-X., Swank, M. W., Kunz, J., & Wu, G.-Y. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2284-05.2005 · Cited by 588 · see citing works

Control of Dendritic Arborization by the Phosphoinositide-3′-Kinase–Akt–Mammalian Target of Rapamycin Pathway

Jaworski, J., Spangler, S. A., Seeburg, D. P., Hoogenraad, C. C., & Sheng, M. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.2270-05.2005 · Cited by 577 · see citing works

Phosphatidylinositol 3-Kinase and Akt Protein Kinase Are Necessary and Sufficient for the Survival of Nerve Growth Factor-Dependent Sympathetic Neurons

Crowder, R. J., & Freeman, R. S. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-08-02933.1998 · Cited by 575 · see citing works

Endoplasmic Reticulum Stress and the Unfolded Protein Response in Cellular Models of Parkinson's Disease

Ryu, E. J., Harding, H. P., Angelastro, J. M., Vitolo, O. V., Ron, D., & Greene, L. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10690.2002 · Cited by 572 · see citing works

Phosphorylation of Mammalian Target of Rapamycin (mTOR) at Ser-2448 IsMediated by p70S6 Kinase

Chiang, G. G., & Abraham, R. T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501707200 · Cited by 562 · see citing works

Identification of a Novel Hypoxia-Inducible Factor 1-Responsive Gene, <i>RTP801</i> , Involved in Apoptosis

Shoshani, T., Faerman, A., Mett, I., Zelin, E., Tenne, T., Gorodin, S., Moshel, Y., Elbaz, S., Budanov, A., Chajut, A., et al. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2283-2293.2002 · Cited by 546 · see citing works

REDD1, a Developmentally Regulated Transcriptional Target of p63 and p53, Links p63 to Regulation of Reactive Oxygen Species

Ellisen, L. W., Ramsayer, K. D., Johannessen, C. M., Yang, A., Beppu, H., Minda, K., Oliner, J. D., McKeon, F., & Haber, D. A. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00706-2 · Cited by 474 · see citing works

Axonal -synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease

Orimo, S., Uchihara, T., Nakamura, A., Mori, F., Kakita, A., Wakabayashi, K., & Takahashi, H. (2007) · Brain · doi:10.1093/brain/awm302 · Cited by 462 · see citing works

Regulation of mTOR and Cell Growth in Response to Energy Stress by REDD1

Sofer, A., Lei, K., Johannessen, C. M., & Ellisen, L. W. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.14.5834-5845.2005 · Cited by 449 · see citing works

Role of mTOR in physiology and pathology of the nervous system

Swiech, L., Perycz, M., Malik, A., & Jaworski, J. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.08.015 · Cited by 338 · see citing works

Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling

Yang, Y., Gehrke, S., Haque, M. E., Imai, Y., Kosek, J. C., Yang, L., Beal, M. F., Nishimura, I., Wakamatsu, K., Ito, S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504610102 · Cited by 338 · see citing works

Raf and Akt Mediate Distinct Aspects of Sensory Axon Growth

Markus, A., Zhong, J., & Snider, W. D. (2002) · Neuron · doi:10.1016/s0896-6273(02)00752-3 · Cited by 327 · see citing works

PRAS40 and PRR5-Like Protein Are New mTOR Interactors that Regulate Apoptosis

Thedieck, K., Polak, P., Kim, M. L., Molle, K. D., Cohen, A., Jenö, P., Arrieumerlou, C., & Hall, M. N. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001217 · Cited by 290 · see citing works

Activated Phosphatidylinositol 3-Kinase and Akt Kinase Promote Survival of Superior Cervical Neurons

Philpott, K. L., McCarthy, M. J., Klippel, A., & Rubin, L. L. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.139.3.809 · Cited by 242 · see citing works

The Stress-inducted Proteins RTP801 and RTP801L Are Negative Regulators of the Mammalian Target of Rapamycin Pathway

Corradetti, M. N., Inoki, K., & Guan, K.-L. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c400557200 · Cited by 237 · see citing works

RTP801 Is Elevated in Parkinson Brain Substantia Nigral Neurons and Mediates Death in Cellular Models of Parkinson's Disease by a Mechanism Involving Mammalian Target of Rapamycin Inactivation

Malagelada, C., Ryu, E. J., Biswas, S. C., Jackson-Lewis, V. R., & Greene, L. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3292-06.2006 · Cited by 189 · see citing works

Morphometry of the human substantia nigra in ageing and Parkinson’s disease

Rudow, G. L., O’Brien, R., Savonenko, A. V., Resnick, S. M., Zonderman, A. B., Pletniková, O., Marsh, L., Dawson, T. M., Crain, B. J., West, M. J., et al. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0352-8 · Cited by 184 · see citing works

Oncoprotein Akt/PKB induces trophic effects in murine models of Parkinson's disease

Ries, V., Henchcliffe, C., Kareva, T., Rzhetskaya, M., Bland, R. J., During, M. J., Kholodilov, N. G., & Burke, R. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606401103 · Cited by 168 · see citing works

Neuronal macroautophagy: From development to degeneration

Boland, B., & Nixon, R. A. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2006.08.009 · Cited by 156 · see citing works

Dexamethasone-induced Gene 2 (dig2) Is a Novel Pro-survival Stress Gene Induced Rapidly by Diverse Apoptotic Signals

Wang, Z., Malone, M. H., Thomenius, M. J., Zhong, F., Xu, F., & Distelhorst, C. W. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303723200 · Cited by 144 · see citing works

REDD1 integrates hypoxia-mediated survival signaling downstream of phosphatidylinositol 3-kinase

Schwarzer, R., Tondera, D., Arnold, W., Giese, K., Klippel, A., & Kaufmann, J. (2004) · Oncogene · doi:10.1038/sj.onc.1208236 · Cited by 129 · see citing works

Inhibition of Oxygen-Induced Retinopathy in RTP801-Deficient Mice

Brafman, A., Mett, I. L., Shafir, M., Gottlieb, H., Damari, G. M., Gozlan-Kelner, S., Vishnevskia‐Dai, V., Skaliter, R., Einat, P., Faerman, A., et al. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-0052 · Cited by 128 · see citing works

Analysis of gene expression changes in a cellular model of Parkinson disease

Ryu, E. J., Angelastro, J. M., & Greene, L. A. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.08.016 · Cited by 95 · see citing works

FKHRL1 and its homologs are new targets of nerve growth factor Trk receptor signaling

Zheng, W., Kar, S., & Quirion, R. (2002) · Journal of Neurochemistry · doi:10.1046/j.0022-3042.2002.00783.x · Cited by 89 · see citing works

Invited Article: Changing concepts in Parkinson disease

Marras, C., & Lang, A. E. (2008) · Neurology · doi:10.1212/01.wnl.0000312515.52545.51 · Cited by 85 · see citing works

A Golgi study of human locus coeruleus in normal brains and in Parkinson's disease

Patt, S., & Gerhard, L. (1993) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1993.tb00480.x · Cited by 64 · see citing works

Medical treatment of Parkinson’s disease

Fahn, S. (1998) · Journal of Neurology · doi:10.1007/pl00007742 · Cited by 38 · see citing works

PC12 Cells as a model for parkinson's disease research

Malagelada, C., & Greene, L. A. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-374028-1.00029-4 · Cited by 27 · see citing works

The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration

Heras-Sandoval, D., Pérez-Rojas, J. M., Hernández-Damián, J., & Pedraza-Chaverri, J. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.08.019 · Cited by 1,091 · see citing works

Human iPSC-based modeling of late-onset disease via progerin-induced aging

Miller, J. D., Ganat, Y. M., Kishinevsky, S., Bowman, R. L., Liu, B., Tu, E. Y., Mandal, P. K., Vera, E., Shim, J.-W., Kriks, S., et al. (2013) · Cell stem cell · doi:10.1016/j.stem.2013.11.006 · Cited by 777 · see citing works

Fighting neurodegeneration with rapamycin: mechanistic insights

Bové, J., Martínez‐Vicente, M., & Vila, M. (2011) · Nature reviews. Neuroscience · doi:10.1038/nrn3068 · Cited by 525 · see citing works

Pharmacological rescue of mitochondrial deficits in iPSC-derived neural cells from patients with familial Parkinson’s disease

Cooper, O., Seo, H., Andrabi, S., Guardia-Laguarta, C., Graziotto, J., Sundberg, M., McLean, J. R., Carrillo-Reid, L., Xie, Z., Osborn, T., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003985 · Cited by 508 · see citing works

The Role of PI3K/Akt and ERK in Neurodegenerative Disorders

Nand, S., Dilnashin, H., Birla, H., Singh, S. S., Zahra, W., Singh, B. K., Singh, S. P., & Singh, S. P. (2019) · Neurotoxicity Research · doi:10.1007/s12640-019-0003-y · Cited by 480 · see citing works

Rapamycin Protects against Neuron Death inIn VitroandIn VivoModels of Parkinson's Disease

Malagelada, C., Jin, Z. H., Jackson-Lewis, V. R., Przedborski, S., & Greene, L. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3944-09.2010 · Cited by 458 · see citing works

The glucagon-like peptide 1 (GLP) receptor as a therapeutic target in Parkinson's disease: mechanisms of action

Athauda, D., & Foltynie, T. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.013 · Cited by 383 · see citing works

mTOR in Brain Physiology and Pathologies

Bockaert, J., & Marin, P. (2015) · Physiological Reviews · doi:10.1152/physrev.00038.2014 · Cited by 360 · see citing works

Insulin resistance and Parkinson’s disease: A new target for disease modification?

Athauda, D. S., & Foltynie, T. (2016) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.10.001 · Cited by 333 · see citing works

mTORC2 controls actin polymerization required for consolidation of long-term memory

Huang, W., Zhu, P. J., Zhang, S., Zhou, H., Stoica, L., Galiano, M., Krnjević, K., Roman, G., & Costa-Mattioli, M. (2013) · Nature Neuroscience · doi:10.1038/nn.3351 · Cited by 307 · see citing works

The Therapeutic Potential of Metformin in Neurodegenerative Diseases

Rotermund, C., Machetanz, G., & Fitzgerald, J. C. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00400 · Cited by 310 · see citing works

Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment

Kopp, K. O., Glotfelty, E. J., Li, Y., & Greig, N. H. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106550 · Cited by 298 · see citing works

Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration

Querfurth, H., & Lee, H.-K. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00428-5 · Cited by 288 · see citing works

Cell death pathways in Parkinson’s disease: proximal triggers, distal effectors, and final steps

Levy, O. A., Malagelada, C., & Greene, L. A. (2009) · APOPTOSIS · doi:10.1007/s10495-008-0309-3 · Cited by 287 · see citing works

Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease

Golpich, M., Amini, E., Hemmati, F., Ibrahim, N. M., Rahmani, B., Mohamed, Z., Raymond, A. A., Dargahi, L., Ghasemi, R., & Ahmadiani, A. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.03.010 · Cited by 276 · see citing works

Shaping the Nrf2-ARE-related pathways in Alzheimer’s and Parkinson’s diseases

Fão, L., Mota, S. I., & Rego, A. C. (2019) · Ageing Research Reviews · doi:10.1016/j.arr.2019.100942 · Cited by 270 · see citing works

Inhibition of mTOR Signaling in Parkinson’s Disease Prevents l -DOPA–Induced Dyskinesia

Santini, E., Heiman, M., Greengard, P., Valjent, E., & Fisone, G. (2009) · Science Signaling · doi:10.1126/scisignal.2000308 · Cited by 256 · see citing works

Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease

Athauda, D. S., Gulyani, S., Karnati, H. K., Li, Y., Tweedie, D., Mustapić, M., Chawla, S., Chowdhury, K., Skene, S. S., Greig, N. H., et al. (2019) · JAMA Neurology · doi:10.1001/jamaneurol.2018.4304 · Cited by 259 · see citing works

Neurotoxin-induced ER stress in mouse dopaminergic neurons involves downregulation of TRPC1 and inhibition of AKT/mTOR signaling

Selvaraj, S., Sun, Y., Watt, J. A., Wang, S., Lei, S., Birnbaumer, L., & Singh, B. B. (2012) · Journal of Clinical Investigation · doi:10.1172/jci61332 · Cited by 245 · see citing works

Neuroprotective actions of sex steroids in Parkinson’s disease

Bourque, M., Dluzen, D. E., & Paolo, T. D. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2009.04.014 · Cited by 239 · see citing works

The Role of Insulin/IGF-1/PI3K/Akt/GSK3β Signaling in Parkinson's Disease Dementia

Yang, L., Wang, H., Liu, L., & Xie, A. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00073 · Cited by 228 · see citing works

Akt signal transduction dysfunction in Parkinson's disease

Timmons, S., Coakley, M. F., Moloney, A. M., & Neill, C. O. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.09.055 · Cited by 192 · see citing works

Mitochondrial pyruvate carrier regulates autophagy, inflammation, and neurodegeneration in experimental models of Parkinson’s disease

Ghosh, A., Tyson, T., George, S., Hildebrandt, E. N., Steiner, J. A., Madaj, Z., Schulz, E., Machiela, E., McDonald, W. G., Galvis, M. L. E., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aag2210 · Cited by 187 · see citing works

The Chemical Biology of Ferroptosis in the Central Nervous System

Ratan, R. R. (2020) · Cell chemical biology · doi:10.1016/j.chembiol.2020.03.007 · Cited by 181 · see citing works

Targeting ROS-Dependent AKT/GSK-3β/NF-κB and DJ-1/Nrf2 Pathways by Dapagliflozin Attenuates Neuronal Injury and Motor Dysfunction in Rotenone-Induced Parkinson’s Disease Rat Model

Arab, H. H., Safar, M. M., & Shahin, N. N. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00722 · Cited by 180 · see citing works

Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson’s disease

Tonges, L., Frank, T., Tatenhorst, L., Saal, K. A., Koch, J. C., Szego, E. M., Bahr, M., Weishaupt, J. H., & Lingor, P. (2012) · Brain · doi:10.1093/brain/aws254 · Cited by 176 · see citing works

Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson's disease

Xu, Y., Liu, C., Chen, S., Ye, Y., Guo, M., Ren, Q., Liu, L., Zhang, H., Xu, C., Zhou, Q., et al. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.04.009 · Cited by 171 · see citing works

Mitochondria, OxPhos, and neurodegeneration: cells are not just running out of gas

Área-Gómez, E., Guardia‐Laguarta, C., Schon, E. A., & Przedborski, S. (2019) · Journal of Clinical Investigation · doi:10.1172/jci120848 · Cited by 169 · see citing works

DJ-1 protects the nigrostriatal axis from the neurotoxin MPTP by modulation of the AKT pathway

Aleyasin, H., Rousseaux, M. W. C., Marcogliese, P. C., Hewitt, S. J., Irrcher, I., Joselin, A. P., Parsanejad, M., Kim, R. H., Rizzu, P., Callaghan, S. M., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914876107 · Cited by 168 · see citing works

Novel tactics for neuroprotection in Parkinson's disease: role of antibiotics, polyphenols and neuropeptides

Reglodi, D., Renaud, J., Tamas, A., Tizabi, Y., Socías, S. B., Del-Bel, E., & Raisman-Vozari, R. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2015.10.004 · Cited by 162 · see citing works

Mucuna pruriens Protects against MPTP Intoxicated Neuroinflammation in Parkinson’s Disease through NF-κB/pAKT Signaling Pathways

Rai, S. N., Birla, H., Singh, S. S., Zahra, W., Patil, R. R., Jadhav, J. P., Gedda, M. R., & Singh, S. P. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00421 · Cited by 161 · see citing works

Mammalian Target of Rapamycin: Hitting the Bull′s‐Eye for Neurological Disorders

Chong, Z. Z., Shang, Y., Zhang, L., Wang, S., & Maiese, K. (2010) · Oxidative Medicine and Cellular Longevity · doi:10.4161/oxim.3.6.14787 · Cited by 149 · see citing works

Disrupted iron homeostasis causes dopaminergic neurodegeneration in mice

Matak, P., Matak, A., Moustafa, S. M., Aryal, D. K., Benner, E. J., Wetsel, W. C., & Andrews, N. C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1519473113 · Cited by 133 · see citing works

ATF4 protects against neuronal death in cellular PD models by maintaining levels of parkin

Sun, X., Liu, J., Crary, J. F., Malagelada, C., Sulzer, D., Greene, L., & Levy, O. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.2292-12.2013 · Cited by 123 · see citing works

Integral Characterization of Defective BDNF/TrkB Signalling in Neurological and Psychiatric Disorders Leads the Way to New Therapies

Tejeda, G., & Díaz-Guerra, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18020268 · Cited by 126 · see citing works

Ursocholanic acid rescues mitochondrial function in common forms of familial Parkinson’s disease

Mortiboys, H., Aasly, J. O., & Bandmann, O. (2013) · Brain · doi:10.1093/brain/awt224 · Cited by 124 · see citing works

Downregulation of Akt/Mammalian Target of Rapamycin Pathway in Skeletal Muscle Is Associated with Increased REDD1 Expression in Response to Chronic Hypoxia

Favier, F. B., Costes, F., Defour, A., Bonnefoy, R., Lefai, E., Baugé, S., Peinnequin, A., Benoit, H., & Freyssenet, D. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00550.2009 · Cited by 127 · see citing works

mTOR Signaling in Parkinson’s Disease

Lan, A., Chen, J., Zhao, Y., Chai, Z., & Hu, Y. (2016) · NeuroMolecular Medicine · doi:10.1007/s12017-016-8417-7 · Cited by 115 · see citing works

The Relevance of Insulin Action in the Dopaminergic System

Fiory, F., Perruolo, G., Cimmino, I., Cabaro, S., Pignalosa, F. C., Miele, C., Bèguinot, F., Formisano, P., & Oriente, F. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00868 · Cited by 114 · see citing works

Therapeutic Effects of Rapamycin on MPTP-Induced Parkinsonism in Mice

Liu, K., Shi, N., Sun, Y., Zhang, T., & Sun, X. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0909-8 · Cited by 114 · see citing works

Rotenone Induction of Hydrogen Peroxide Inhibits mTOR-mediated S6K1 and 4E-BP1/eIF4E Pathways, Leading to Neuronal Apoptosis

Zhou, Q., Liu, C., Liu, W., Zhang, H., Zhang, R., Liu, J., Zhang, J., Xu, C., Liu, L., Huang, S., et al. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu211 · Cited by 104 · see citing works

Multifaceted deaths orchestrated by mitochondria in neurones

Nagley, P., Higgins, G. C., Atkin, J. D., & Beart, P. M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2009.09.004 · Cited by 103 · see citing works

Ferroptosis regulation through Nrf2 and implications for neurodegenerative diseases

Xiang, Y., Song, X., & Long, D. (2024) · Archives of Toxicology · doi:10.1007/s00204-023-03660-8 · Cited by 109 · see citing works

Glucocorticoids Modulate the mTOR Pathway in the Hippocampus: Differential Effects Depending on Stress History

Polman, J. A. E., Hunter, R. G., Speksnijder, N., van den Oever, J. M. E., Korobko, O. B., McEwen, B. S., de Kloet, E. R., & Datson, N. A. (2012) · Endocrinology · doi:10.1210/en.2012-1255 · Cited by 100 · see citing works

Neuroprotection by Paeoniflorin in the MPTP mouse model of Parkinson's disease

Zheng, M., Liu, C., Fan, Y., Yan, P., Shi, D., & Zhang, Y. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.01.009 · Cited by 100 · see citing works

Hexokinase activity is required for recruitment of parkin to depolarized mitochondria

McCoy, M. K., Kaganovich, A., Rudenko, I. N., Ding, J., & Cookson, M. R. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt407 · Cited by 97 · see citing works

Emerging therapies for Parkinson's disease: From bench to bedside

Tarazi, F. I., Sahli, Z. T., Wolny, M., & Mousa, S. A. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.05.010 · Cited by 96 · see citing works

Reappraisal of metabolic dysfunction in neurodegeneration: Focus on mitochondrial function and calcium signaling

Jadiya, P., Garbincius, J. F., & Elrod, J. W. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01224-4 · Cited by 94 · see citing works

Molecular changes in the postmortem parkinsonian brain

Toulorge, D., Schapira, A. H. V., & Hajj, R. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13696 · Cited by 92 · see citing works

From the cell to the clinic: A comparative review of the partial D2/D3 receptor agonist and α2-adrenoceptor antagonist, piribedil, in the treatment of Parkinson's disease

Millan, M. J. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.06.002 · Cited by 91 · see citing works

Akt Phosphorylates NQO1 and Triggers its Degradation, Abolishing Its Antioxidative Activities in Parkinson's Disease

Luo, S., Kang, S. S., Wang, Z.-H., Liu, X., Day, J. X., Wu, Z., Peng, J., Xiang, D., Springer, W., & Ye, K. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0625-19.2019 · Cited by 83 · see citing works

Diabetes, a Contemporary Risk for Parkinson’s Disease: Epidemiological and Cellular Evidences

Sergi, D., Renaud, J., Simola, N., & Martinoli, M. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00302 · Cited by 85 · see citing works

Effects of DDIT4 in Methamphetamine-Induced Autophagy and Apoptosis in Dopaminergic Neurons

Li, B., Chen, R., Chen, L., Qiu, P., Ai, X., Huang, E., Huang, W., Chen, C., Liu, C., Lin, Z., et al. (2016) · Molecular Neurobiology · doi:10.1007/s12035-015-9637-9 · Cited by 86 · see citing works

Parkinson’s disease-implicated kinases in the brain; insights into disease pathogenesis

Dzamko, N. L., Zhou, J., Huang, Y. M., & Halliday, G. M. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00057 · Cited by 82 · see citing works

Oestrogen Receptors and Signalling Pathways: Implications for Neuroprotective Effects of Sex Steroids in Parkinson’s Disease

Al-Sweidi, S., Sánchez, M. G., Bourque, M., Morissette, M., Dluzen, D. E., & Paolo, T. D. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02193.x · Cited by 82 · see citing works

Emerging Role of Ferroptosis in the Pathogenesis of Ischemic Stroke: A New Therapeutic Target?

Bu, Z., Yu, H., Wang, J., He, X., Cui, Y., Feng, J., & Feng, J. (2021) · ASN NEURO · doi:10.1177/17590914211037505 · Cited by 87 · see citing works

MLN4924, an NAE inhibitor, suppresses AKT and mTOR signaling via upregulation of REDD1 in human myeloma cells

Gu, Y., Kaufman, J. L., Bernal, L., Torre, C., Matulis, S. M., Harvey, R. D., Chen, J., Sun, S., Boise, L., & Lonial, S. (2014) · Blood · doi:10.1182/blood-2013-08-521914 · Cited by 81 · see citing works

The role of glycogen synthase kinase 3 beta in neurodegenerative diseases

Yu, H., Xiong, M., & Zhang, Z. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1209703 · Cited by 79 · see citing works

A neuroprotective role for angiogenin in models of Parkinson’s disease

Steidinger, T. U., Standaert, D. G., & Yacoubian, T. A. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07112.x · Cited by 76 · see citing works

Ferroptosis: A potential therapeutic target for neurodegenerative diseases

Vitalakumar, D., Sharma, A., & Flora, S. J. S. (2021) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.22830 · Cited by 73 · see citing works

Is REDD1 a metabolic double agent? Lessons from physiology and pathology

Britto, F. A., Dumas, K., Giorgetti‐Peraldi, S., Ollendorff, V., & Favier, F. B. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00340.2020 · Cited by 70 · see citing works

Therapeutic effect of GLP-1 engineered strain on mice model of Alzheimer’s disease and Parkinson’s disease

Fang, X., Zhou, X., Miao, Y., Han, Y., Wei, J., & Chen, T. (2020) · AMB Express · doi:10.1186/s13568-020-01014-6 · Cited by 70 · see citing works

Signaling pathways mediating the neuroprotective effects of sex steroids and SERMs in Parkinson’s disease

Bourque, M., Dluzen, D. E., & Paolo, T. D. (2012) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2012.02.003 · Cited by 69 · see citing works

Iron Metabolism of the Skeletal Muscle and Neurodegeneration

Hałoń, M., Borkowska, A., Herman-Antosiewicz, A., & Antosiewicz, J. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00165 · Cited by 69 · see citing works

Akt as a Victim, Villain and Potential Hero in Parkinson’s Disease Pathophysiology and Treatment

Greene, L. A., Levy, O., & Malagelada, C. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9671-8 · Cited by 68 · see citing works

Implication of REDD1 in the activation of inflammatory pathways

Pastor, F., Dumas, K., Barthelemy, M., Regazzetti, C., Druelle, N., Peraldi, P., Cormont, M., Tanti, J., & Giorgetti-Peraldi, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-07182-z · Cited by 55 · see citing works

RTP801/REDD1 Regulates the Timing of Cortical Neurogenesis and Neuron Migration

Malagelada, C., López-Toledano, M. A., Willett, R. T., Jin, Z. H., Shelanski, M. L., & Greene, L. A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4011-10.2011 · Cited by 59 · see citing works

Antidiabetic drugs for Alzheimer's and Parkinson's diseases: Repurposing insulin, metformin, and thiazolidinediones

(2020) · International Review of Neurobiology · doi:10.1016/bs.irn.2020.02.010 · Cited by 58 · see citing works

Unraveling Parkinson’s Disease Neurodegeneration: Does Aging Hold the Clues?

Coleman, C., & Martin, I. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223363 · Cited by 59 · see citing works

The stress-responsive protein REDD1 and its pathophysiological functions

Kim, J., Kwon, Y., & Kim, Y. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01056-3 · Cited by 59 · see citing works

RTP801/REDD1: a stress coping regulator that turns into a troublemaker in neurodegenerative disorders

Canal, M., Romaní-Aumedes, J., Martín‐Flores, N., Pérez-Fernández, V., & Malagelada, C. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00313 · Cited by 57 · see citing works

Oxidative Modification and Its Implications for the Neurodegeneration of Parkinson’s Disease

Zhao, J., Yu, S., Zheng, Y., Yang, H., & Zhang, J. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9743-3 · Cited by 55 · see citing works

Lovastatin protects neurite degeneration inLRRK2-G2019Sparkinsonism through activating the Akt/Nrf pathway and inhibiting GSK3β activity

Lin, C., Lin, H.-I., Chen, M., Lai, T.-T., Cao, L., Farrer, M. J., Wu, R., & Chien, C. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw068 · Cited by 54 · see citing works

The protective effect of biochanin A against rotenone-induced neurotoxicity in mice involves enhancing of PI3K/Akt/mTOR signaling and beclin-1 production

El-Sherbeeny, N. A., Soliman, N., Youssef, A. M., El‐Fadeal, N. M. A., El-Abaseri, T. B., Hashish, A. A., Abdelbasset, W. K., Batiha, G. E., & Zaitone, S. A. (2020) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2020.111344 · Cited by 53 · see citing works

Critical cysteines in Akt1 regulate its activity and proteasomal degradation: implications for neurodegenerative diseases

Ahmad, F., Nidadavolu, P., Durgadoss, L., & Ravindranath, V. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.004 · Cited by 53 · see citing works

Nicotinamide N-methyltransferase expression in SH-SY5Y neuroblastoma and N27 mesencephalic neurones induces changes in cell morphology via ephrin-B2 and Akt signalling

Thomas, M. G., Saldanha, M., Mistry, R. J., Dexter, D. T., Ramsden, D. B., & Parsons, R. B. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.200 · Cited by 53 · see citing works

Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinson’s Disease

Labandeira-Garcia, J. L., Rodríguez-Perez, A. I., Villar-Cheda, B., Borrajo, A., Dominguez-Meijide, A., & Guerra, M. J. (2015) · The Neuroscientist · doi:10.1177/1073858414554954 · Cited by 54 · see citing works

The role of NURR1 in metabolic abnormalities of Parkinson’s disease

Al‐Nusaif, M., Yang, Y., Li, S., Cheng, C., & Le, W. (2022) · Molecular Neurodegeneration · doi:10.1186/s13024-022-00544-w · Cited by 52 · see citing works

PI3K/AKT signaling activation by roflumilast ameliorates rotenone-induced Parkinson’s disease in rats

Farid, H. A., Sayed, R. H., El-Shamarka, M. E.-S., Abdel‐Salam, O. M. E., & Sayed, N. S. E. (2023) · Inflammopharmacology · doi:10.1007/s10787-023-01305-x · Cited by 52 · see citing works

Ceramide sphingolipid signaling mediates Tumor Necrosis Factor (TNF)-dependent toxicity via caspase signaling in dopaminergic neurons

Martinez, T. N., Chen, X., Bandyopadhyay, S., Merrill, A. H., & Tansey, M. G. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-45 · Cited by 52 · see citing works

Ras Homolog Enriched in Brain (Rheb) Enhances Apoptotic Signaling*

Karassek, S., Berghaus, C., Schwarten, M., Goemans, C. G., Ohse, N., Kock, G., Jockers, K. F. G., Neumann, S., Gottfried, S., Herrmann, C., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.095968 · Cited by 51 · see citing works

PINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis

Akundi, R. S., Zhi, L., & Büeler, H. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.08.034 · Cited by 50 · see citing works

Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson’s disease

Romaní-Aumedes, J., Canal, M., Martín‐Flores, N., Sun, X., Pérez-Fernández, V., Wewering, S., Fernández‐Santiago, R., Ezquerra, M., Pont‐Sunyer, C., Lafuente, A., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.333 · Cited by 50 · see citing works

Regulation of mRNA Translation as a Conserved Mechanism of Longevity Control

Mehta, R., Chandler-Brown, D., Ramos, F. J., Shamieh, L. S., & Kaeberlein, M. (2010) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4419-7002-2_2 · Cited by 44 · see citing works

Docosahexaenoic acid provides protective mechanism in bilaterally MPTP-lesioned rat model of Parkinson's disease

Hacıoğlu, G., Seval, Y., Tanrιöver, G., Özsoy, Ö., Saka, E., Balkan, S., & Ağar, A. (2012) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.2012.0032 · Cited by 48 · see citing works

MiR-133b ameliorates axon degeneration induced by MPP+ via targeting RhoA

Niu, M., Xu, R., Wang, J., Hou, B., & Xie, A. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.03.042 · Cited by 49 · see citing works

Elevated nuclear phosphatase and tensin homolog (PTEN) and altered insulin signaling in substantia nigral region of patients with Parkinson’s disease

Sekar, S., & Taghibiglou, C. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.12.049 · Cited by 49 · see citing works

Redox modification of Akt mediated by the dopaminergic neurotoxin MPTP, in mouse midbrain, leads to down‐regulation of pAkt

Durgadoss, L., Nidadavolu, P., Valli, R. K., Saeed, U., Mishra, M., Seth, P., & Ravindranath, V. (2011) · The FASEB Journal · doi:10.1096/fj.11-194100 · Cited by 48 · see citing works

Striatal Akt/GSK3 signaling pathway in the development of L-Dopa-induced dyskinesias in MPTP monkeys

Morissette, M., Samadi, P., Tahar, A. H., Bélanger, N., & Di Paolo, T. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.12.011 · Cited by 47 · see citing works

Feedback Control of p53 Translation by REDD1 and mTORC1 Limits the p53-Dependent DNA Damage Response

Vadysirisack, D. D., Baenke, F., Ory, B., Lei, K., & Ellisen, L. W. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05541-11 · Cited by 48 · see citing works

Neuroprotective Effects of Salidroside in the MPTP Mouse Model of Parkinson’s Disease: Involvement of the PI3K/Akt/GSK3βPathway

Zhang, W., He, H., Song, H., Zhao, J., Li, T., Wu, L., Zhang, X., & Chen, J. (2016) · Parkinson s Disease · doi:10.1155/2016/9450137 · Cited by 46 · see citing works

RTP801/REDD1 contributes to neuroinflammation severity and memory impairments in Alzheimer’s disease

Pérez‐Sisqués, L., Sancho‐Balsells, A., Solana‐Balaguer, J., Campoy‐Campos, G., Vives-Isern, M., Soler-Palazón, F., Anglada‐Huguet, M., López-Toledano, M. A., Mandelkow, E., Alberch, J., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03899-y · Cited by 44 · see citing works

FLZ protects dopaminergic neuron through activating protein kinase B/mammalian target of rapamycin pathway and inhibiting RTP801 expression in Parkinson's disease models

Bao, X.-Q., Kong, X., Qian, C., & Zhang, D. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.036 · Cited by 45 · see citing works

Neuroactive gonadal drugs for neuroprotection in male and female models of Parkinson's disease

Litim, N., Morissette, M., & Paolo, T. D. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.09.024 · Cited by 45 · see citing works

The Parkinson's disease gene PINK1 activates Akt via PINK1 kinase-dependent regulation of the phospholipid PI(3,4,5)P3

Furlong, R. M., Lindsay, A. J., Anderson, K. E., Hawkins, P. T., Sullivan, A. M., & O’Neill, C. (2019) · Journal of Cell Science · doi:10.1242/jcs.233221 · Cited by 44 · see citing works

Neuroprotection by tetrahydroxystilbene glucoside in the MPTP mouse model of Parkinson's disease

Zhang, L., Huang, L., Chen, L.-W., Hao, D., & Chen, J. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.07.020 · Cited by 42 · see citing works

Magnolol Protects against MPTP/MPP + -Induced Toxicity via Inhibition of Oxidative Stress in In Vivo and In Vitro Models of Parkinson’s Disease

Muroyama, A., Fujita, A., Lv, C., Kobayashi, S., Fukuyama, Y., & Mitsumoto, Y. (2012) · Parkinson s Disease · doi:10.1155/2012/985157 · Cited by 42 · see citing works

Roles of ERK/Akt signals in mitochondria-dependent and endoplasmic reticulum stress-triggered neuronal cell apoptosis induced by 4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene, a major active metabolite of bisphenol A

Huang, C.-F., Liu, S., Su, C., Fang, K., Yen, C., Yang, C., Tang, F., Liu, J., Wu, C.-C., Lee, K.-I., et al. (2021) · Toxicology · doi:10.1016/j.tox.2021.152764 · Cited by 41 · see citing works

Arsenic induces autophagy-dependent apoptosis via Akt inactivation and AMPK activation signaling pathways leading to neuronal cell death

Fu, S.-C., Lin, J.-W., Liu, J., Liu, S., Fang, K., Su, C., Hsu, R., Wu, C.-C., Huang, C.-F., Lee, K.-I., et al. (2021) · NeuroToxicology · doi:10.1016/j.neuro.2021.05.008 · Cited by 39 · see citing works

Dual Effect of Doxazosin: Anticancer Activity on SH-SY5Y Neuroblastoma Cells and Neuroprotection on an In Vitro Model of Alzheimer's Disease

Coelho, B. P., Gaelzer, M. M., Petry, F. D. S., Hoppe, J. B., Trindade, V. M. T., Salbego, C. G., & Guma, F. T. C. R. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.02.005 · Cited by 38 · see citing works

RTP801 Is Elevated in Parkinson Brain Substantia Nigral Neurons and Mediates Death in Cellular Models of Parkinson's Disease by a Mechanism Involving Mammalian Target of Rapamycin Inactivation

Malagelada, C., Ryu, E. J., Biswas, S. C., Jackson-Lewis, V. R., & Greene, L. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3292-06.2006 · Cited by 189 · see citing works

Activation of AMPK and inactivation of Akt result in suppression of mTOR-mediated S6K1 and 4E-BP1 pathways leading to neuronal cell death in in vitro models of Parkinson's disease

Xu, Y., Liu, C., Chen, S., Ye, Y., Guo, M., Ren, Q., Liu, L., Zhang, H., Xu, C., Zhou, Q., et al. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.04.009 · Cited by 171 · see citing works

RTP801/REDD1: a stress coping regulator that turns into a troublemaker in neurodegenerative disorders

Canal, M., Romaní-Aumedes, J., Martín‐Flores, N., Pérez-Fernández, V., & Malagelada, C. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00313 · Cited by 57 · see citing works

Rapamycin Protects against Neuron Death inIn VitroandIn VivoModels of Parkinson's Disease

Malagelada, C., Jin, Z. H., Jackson-Lewis, V. R., Przedborski, S., & Greene, L. A. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.3944-09.2010 · Cited by 458 · see citing works

RTP801 is a critical factor in the neurodegeneration process of A53T α‐synuclein in a mouse model of Parkinson's disease under chronic restraint stress

Zhang, Z., Chu, S., Wang, S., Jiang, Y., Gao, Y., Yang, P., Ai, Q., & Chen, N. (2017) · British Journal of Pharmacology · doi:10.1111/bph.14091 · Cited by 34 · see citing works